Impact BioMedical, Inc. (IBO)
Impact BioMedical will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$3.00 - $5.00
Shares Offered
1,500,000
Deal Size
$6.00M

Impact BioMedical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20222021
Market Capitalization
46--
Enterprise Value
57--
Debt / Equity Ratio
0.400.310.31
Debt / EBITDA Ratio
-1.74-1.58-6.28
Debt / FCF Ratio
-3.83-3.97-6.18
Quick Ratio
0.030.000.02
Interest Coverage
-16.19-16.98-23.02
Return on Equity (ROE)
-22.01%-22.21%-4.63%
Return on Assets (ROA)
--15.60%-3.28%
Return on Capital (ROIC)
-9.60%-8.10%-6.07%
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).